ABIOMED INC

Delisted

CIK 815094fmd_0W5W6NE2VDT1Y3VQZ41TB6ZG1NManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2022, 51 periods

Income Statement · Annual · Millions · USD
Line item	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Total revenues	158	184	230	330	445	594	769	841	848	1,032
Cost of revenue	32	37	40	50	71	99	130	151	162	188
Gross profit	127	146	190	279	375	495	640	690	686	844
Realized investment gains (losses)	–	–	–	–	–	–	–	–	–	–
Research and development	26	31	36	50	66	75	94	99	122	163
Selling, general and administrative	84	107	126	164	218	263	322	342	334	423
Total operating expenses	110	138	162	214	285	338	415	440	456	–
Operating income	17	8	29	65	90	157	225	249	230	141
Other non-operating income (expense)	0	0	0	1	1	3	39	8	59	50
Income before taxes	17	9	29	66	91	160	263	257	288	191
Income tax expense	2	1	(85)	28	39	48	4	54	63	54
Net income from continuing operations	15	7	114	38	52	112	259	203	226	137
Net income	15	7	114	38	52	112	259	203	226	137